CCP110
Basic information
Region (hg38): 16:19523811-19553408
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCP110 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 43 | 47 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 44 | 2 | 9 |
Variants in CCP110
This is a list of pathogenic ClinVar variants found in the CCP110 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-19527888-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
16-19527924-A-G | not specified | Uncertain significance (Jun 23, 2023) | ||
16-19532441-T-C | not specified | Uncertain significance (Mar 19, 2024) | ||
16-19532474-A-T | not specified | Uncertain significance (Mar 07, 2024) | ||
16-19532516-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
16-19532521-C-G | not specified | Uncertain significance (Jan 10, 2022) | ||
16-19532537-A-G | not specified | Uncertain significance (Mar 23, 2022) | ||
16-19536035-A-G | not specified | Benign (Mar 28, 2016) | ||
16-19536181-C-T | not specified | Benign (Mar 28, 2016) | ||
16-19536365-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
16-19536412-T-C | not specified | Uncertain significance (May 04, 2022) | ||
16-19536425-C-G | not specified | Benign (Mar 28, 2016) | ||
16-19536521-CTG-C | See cases | Likely pathogenic (Dec 25, 2023) | ||
16-19536547-C-G | not specified | Uncertain significance (Jul 20, 2022) | ||
16-19536594-G-A | not specified | Uncertain significance (Jun 11, 2021) | ||
16-19536603-A-C | not specified | Uncertain significance (Jan 03, 2024) | ||
16-19536637-T-C | not specified | Uncertain significance (Feb 28, 2023) | ||
16-19536642-A-C | not specified | Uncertain significance (Mar 26, 2024) | ||
16-19536757-A-G | not specified | Uncertain significance (Jun 16, 2024) | ||
16-19536787-C-T | not specified | Uncertain significance (Mar 26, 2024) | ||
16-19536794-G-A | not specified | Benign (Mar 28, 2016) | ||
16-19536798-C-T | See cases | Likely pathogenic (Dec 25, 2023) | ||
16-19536799-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
16-19536810-A-G | not specified | Uncertain significance (Jan 03, 2022) | ||
16-19536838-T-C | not specified | Uncertain significance (Jun 02, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCP110 | protein_coding | protein_coding | ENST00000381396 | 14 | 29598 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00668 | 0.993 | 125698 | 0 | 46 | 125744 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.28 | 437 | 519 | 0.842 | 0.0000254 | 6677 |
Missense in Polyphen | 171 | 216.07 | 0.7914 | 2852 | ||
Synonymous | 1.91 | 145 | 177 | 0.818 | 0.00000904 | 1862 |
Loss of Function | 4.46 | 13 | 45.5 | 0.286 | 0.00000226 | 609 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000431 | 0.000427 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000385 | 0.000381 |
Finnish | 0.0000979 | 0.0000924 |
European (Non-Finnish) | 0.000195 | 0.000193 |
Middle Eastern | 0.000385 | 0.000381 |
South Asian | 0.000165 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Necessary for centrosome duplication at different stages of procentriole formation. Acts as a key negative regulator of ciliogenesis in collaboration with CEP97 by capping the mother centriole thereby preventing cilia formation (PubMed:17719545 PubMed:17681131, PubMed:23486064). Also involved in promoting ciliogenesis. May play a role in the assembly of the mother centriole subdistal appendages (SDA) thereby effecting the fusion of recycling endosomes to basal bodies during cilia formation (By similarity). Required for correct spindle formation and has a role in regulating cytokinesis and genome stability via cooperation with CALM1 and CETN2 (PubMed:16760425). {ECO:0000250|UniProtKB:Q7TSH4, ECO:0000269|PubMed:12361598, ECO:0000269|PubMed:16760425, ECO:0000269|PubMed:17681131, ECO:0000269|PubMed:17719545, ECO:0000269|PubMed:23486064}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Regulation of PLK1 Activity at G2/M Transition;Recruitment of mitotic centrosome proteins and complexes;Loss of Nlp from mitotic centrosomes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Ub-specific processing proteases;AURKA Activation by TPX2;G2/M Transition;Mitotic G2-G2/M phases;Deubiquitination;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic;Anchoring of the basal body to the plasma membrane;Cilium Assembly;Organelle biogenesis and maintenance
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.35
- rvis_percentile_EVS
- 29.54
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.270
- ghis
- 0.535
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccp110
- Phenotype
- craniofacial phenotype; cellular phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; digestive/alimentary phenotype; vision/eye phenotype; skeleton phenotype; renal/urinary system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- G2/M transition of mitotic cell cycle;centriole replication;regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;ciliary basal body organization;regulation of cytokinesis;positive regulation of cilium assembly;centrosome duplication;ciliary basal body-plasma membrane docking;negative regulation of cilium assembly
- Cellular component
- centrosome;centriole;cytosol;cilium;protein-containing complex
- Molecular function
- protein binding